If you tested positive for COVID-19 no more than 3 days ago and have certain risk factors that could make a COVID-19 infection worse, you can be of tremendous help to the medical community by participating in a research study to evaluate Regeneron’s investigational COVID-19 antibody cocktail to see if it can treat COVID-19 in people with risk factors.
Participation in clinical research is one way for people to contribute to the worldwide search for COVID-19 treatments. See if you qualify today to become a Research Study Rockstar!
There is no cost to participate and you may be compensated up to $3,650.